Skip to content

Calcium drink trial for PBSC collection

Open-lable, randomized controlled study to calcium drink for prevention of citrate toxicity during peripheral blood stem cell collection from healthy donors.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs061200035
Enrollment
42
Registered
2020-12-09
Start date
2021-01-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healty donors donor

Interventions

drinking before staritng peripheral strem cell collection

Sponsors

Fujii Keiko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: healthy donors

Exclusion criteria

Exclusion criteria: active infectious desease

Design outcomes

Primary

MeasureTime frame
Incidence of citrate toxicity; Grade 1 or higher

Secondary

MeasureTime frame
Incidence of citrate toxicity ; Grade 2 or higher Incidence of citrate toxicity ; Grade 3 or higher Reduction rate of ionized calcium level safety

Contacts

Public ContactKeiko Fujii

Okayama University Hospital

keikofujii@okayama-u.ac.jp+81-86-235-7768

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026